Ovarian Cancer Market by Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, and Primary Peritoneal Carcinoma), by Cancer Stage (Stage I, Stage II, Stage III, and Stage IV), by Diagnostics (Physical Examination, Biopsy, Blood Tests, Human Chorionic Gonadotropin (hCG) test, ultrasound, MRI, PET, and CT scans), and by Treatment (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, and Surgery): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Global ovarian cancer market expected to generate revenue of around USD 4.01 billion by end of 2024, growing at a CAGR of around 11.82% between 2018 and 2024. Ovaries are located on each side of the uterus and are a part of the female reproductive system. Ovaries produce ovum and female hormones progesterone and estrogen.

Request Brochure Request Discount

11-Aug-2018 | Number of pages: 110 | Report Code: ZMR-3037 | Report Format : | Status : Published

Abstract

The report covers the forecast and analysis for the ovarian cancer market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the ovarian cancer market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the ovarian cancer market on a global level.
In order to give the users of this report a comprehensive view of the ovarian cancer market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, where type, cancer stage, diagnostic, treatment, and regional segmentations are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

Global Ovarian Cancer Market

The study provides a decisive view of the ovarian cancer market by segmenting the market based on type, cancer stage, diagnostic, treatment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

The ovarian cancer market is classified based on type, cancer stage, diagnostic, treatment, and region. On the basis of type, the market is divided epithelial ovarian tumors, ovarian germ cell tumors, ovarian stromal tumors, and primary peritoneal carcinoma. On the basis of cancer stage market is segmented as Stage I, Stage II, Stage III, and Stage IV. On the basis of diagnostics, the market is divided into chemotherapy, targeted therapy, radiation therapy, human chorionic gonadotropin (hCG) test, ultrasound, MRI (Magnetic resonance imaging), PET (Positron emission tomography), and CT scans. On the basis of treatment, the market is divided into chemotherapy, targeted therapy, radiation therapy, immunotherapy, hormonal therapy, and surgery.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and The Middle East & Africa with its further bifurcation into major countries including the U.S., Germany, France, U.K., China, Japan, India, and Brazil. This segmentation includes demand for ovarian cancer market based on the individual segment in all the regions and countries.

The report also includes detailed profiles of end players such as Astra Zeneca Plc, Bristol Myers Squibb Company, Genentech Inc., Eli Lilly and Company, Novogen, Inc., GlaxoSmithKline Plc, Janssen Pharmaceuticals, Inc., Aetera Zenteris Inc., Boehringer Ingelheim GmbH, F. Hoffman-La Roche Ltd., and others.
 
This report segments the global ovarian cancer market as follows:

Global Ovarian Cancer Market: by Type

  • Epithelial Ovarian Tumors 
  • Ovarian Germ Cell Tumors
  • Ovarian Stromal Tumors 
  • Primary Peritoneal Carcinoma

Global Ovarian Cancer Market: by Cancer Stage

  • Stage I
  • Stage II
  • Stage III
  • Stage IV 

Global Ovarian Cancer Market: by Diagnostic

  • Chemotherapy
  • Targeted Therapy
  • Radiation Therapy

Human Chorionic Gonadotropin (hCG) test

  • Ultrasound
  • MRI
  • PET
  • CT scans

Global Ovarian Cancer Market: by Treatment

  • Chemotherapy
  • Targeted Therapy
  • Radiation Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Surgery

Global Ovarian Cancer Market: by Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Parenteral Nutrition Market by Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins and Minerals) and by End-users (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3277 | Report Format:

The report covers forecast and analysis for the parenteral nutrition market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the parente...Read More

Hereditary Cancer Testing Market by Diagnosis Type (Biopsy, Imaging and Others), By End-User (Hospitals, Clinics, and Diagnostic Centers), and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3262 | Report Format:

The report covers forecast and analysis for the hereditary cancer testing market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hereditary cancer ...Read More

Metastatic Bone Disease Market by Treatment (Medication, Radiation Therapy, Surgical Intervention, and Tumor Ablation Therapy), by Origin (Breast, Lung, Thyroid, Kidney, Prostate & Others), and by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3243 | Report Format:

The report covers forecast and analysis for the metastatic bone disease market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the metastatic bone dise...Read More

Blood Glucose Test Strips Market by Drug Technology (Channel Technology and Wicking Technology), By Sales Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3239 | Report Format:

The report covers forecast and analysis for the blood glucose test strips market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the blood gluc...Read More

Active Wound Care Market by Product Type (Synthetic Skin Grafts, Allograft, Xenografts, Amniotic Tissue Grafts, Collagen Dressings, and Growth Factors); by Wound Type (Surgical Wounds, Ulcers [Pressure Ulcers, Diabetic Foot Ulcers, Arterial Ulcers, and Venous Ulcers], and Other Wounds), and by End Users (In-Patient Facilities and Out-Patient Facilities): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3238 | Report Format:

The report covers forecast and analysis for the active wound care market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the active wound care market along wi...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.